{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:27:41Z","timestamp":1758637661440,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["S1411019"],"award-info":[{"award-number":["S1411019"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11418-019-01283-x","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T11:01:37Z","timestamp":1549710097000},"page":"468-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analyses of the possible anti-tumor effect of yokukansan"],"prefix":"10.1007","volume":"73","author":[{"given":"Cheolsun","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashige","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junna","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Makabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhide","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kuzumaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1158\/0008-5472.CAN-11-3292","volume":"72","author":"DK Sarkar","year":"2012","unstructured":"Sarkar DK, Murugan S, Zhang C, Boyadjieva N (2012) Regulation of cancer progression by \u03b2-endorphin neuron. Cancer Res 72:836\u2013840. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3292","journal-title":"Cancer Res"},{"key":"1283_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2012.06.015","volume":"30","author":"ND Powell","year":"2013","unstructured":"Powell ND, Tarr AJ, Sheridan JF (2013) Psychosocial stress and inflammation in cancer. Brain Behav Immun 30:41\u201347. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2012.06.015","journal-title":"Brain Behav Immun"},{"key":"1283_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/ijms17060842","volume":"17","author":"DD Cao","year":"2016","unstructured":"Cao DD, Li L, Chan WY (2016) MicroRNAs: key regulators in the central nervous system and their implication in neurological diseases. Int J Mol Sci 17:842. \nhttps:\/\/doi.org\/10.3390\/ijms17060842","journal-title":"Int J Mol Sci"},{"key":"1283_CR4","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.1523\/JNEUROSCI.0921-11.2011","volume":"31","author":"S Imai","year":"2011","unstructured":"Imai S, Saeki M, Yanase M, Horiuchi H, Abe M, Narita M, Kuzumaki N, Suzuki T, Narita M (2011) Change in MicroRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J Neurosci 31:15294\u201315299. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.0921-11.2011","journal-title":"J Neurosci"},{"key":"1283_CR5","first-page":"47","volume":"8","author":"H Saisu","year":"2015","unstructured":"Saisu H, Igarashi K, Narita M, Ikegami D, Kuzumaki N, Wajima K, Nakagawa T, Narita M (2015) Neuropathic pain-like stimuli change the expression of ribosomal proteins in the amygdala: genome-wide search for a \u201cpain-associated anxiety-related factor\u201d. Jpn J Pharm Palliat Care Sci 8:47\u201357","journal-title":"Jpn J Pharm Palliat Care Sci"},{"key":"1283_CR6","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.2174\/13816128113199990519","volume":"20","author":"HF Zhang","year":"2014","unstructured":"Zhang HF, Xu LY, Li EM (2014) A\u00a0family\u00a0of\u00a0pleiotropically\u00a0acting\u00a0microRNAs in\u00a0cancer\u00a0progression,\u00a0miR-200: potential\u00a0cancer\u00a0therapeutic targets. Curr Pharm Des 20:1896\u20131903","journal-title":"Curr Pharm Des"},{"key":"1283_CR7","doi-asserted-by":"publisher","first-page":"e0172115","DOI":"10.1371\/journal.pone.0172115","volume":"12","author":"M Narita","year":"2017","unstructured":"Narita M, Shimura E, Nagasawa A, Aiuchi T, Suda Y, Hamada Y, Ikegami D, Iwasawa C, Arakawa K, Igarashi K, Kuzumaki N, Yoshioka Y, Ochiya T, Takeshima H, Ushijima T, Narita M (2017) Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c. PLoS One 12:e0172115. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0172115","journal-title":"PLoS One"},{"key":"1283_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13:800\u2013812. \nhttps:\/\/doi.org\/10.1038\/nrc3610","journal-title":"Nat Rev Cancer"},{"key":"1283_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/368736","author":"MH Nelson","year":"2015","unstructured":"Nelson MH, Diven MA, Huff LW, Paulos CM (2015) Harnessing the microbiome to enhance cancer immunotherapy. J Immunol Res. \nhttps:\/\/doi.org\/10.1155\/2015\/368736","journal-title":"J Immunol Res"},{"key":"1283_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","volume":"165","author":"L Zitvogel","year":"2016","unstructured":"Zitvogel L, Ayyoub M, Routy B, Kroemer G (2016) Microbiome and anticancer immunosurveillance. Cell 165:276\u2013287. \nhttps:\/\/doi.org\/10.1016\/j.cell.2016.03.001","journal-title":"Cell"},{"key":"1283_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2016.11.013","volume":"105","author":"SE Erdman","year":"2017","unstructured":"Erdman SE, Poutahidis T (2017) Gut microbiota modulate host immune cells in cancer development and growth. Free Radic Biol Med 105:28\u201334. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.11.013","journal-title":"Free Radic Biol Med"},{"key":"1283_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2016.06.018","volume":"166","author":"Y Ikarashi","year":"2016","unstructured":"Ikarashi Y, Mizoguchi K (2016) Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. Pharmacol Ther 166:84\u201395. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.018","journal-title":"Pharmacol Ther"},{"key":"1283_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jep.2012.07.007","volume":"143","author":"T Yamaguchi","year":"2012","unstructured":"Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M (2012) Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. J Ethnopharmacol 143:533\u2013539. \nhttps:\/\/doi.org\/10.1016\/j.jep.2012.07.007","journal-title":"J Ethnopharmacol"},{"key":"1283_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12906-017-1710-7","volume":"17","author":"H Fujiwara","year":"2017","unstructured":"Fujiwara H, Han Y, Ebihara K, Awale S, Araki R, Yabe T, Matsumoto K (2017) Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice. BMC Complement Altern Med 17:195. \nhttps:\/\/doi.org\/10.1186\/s12906-017-1710-7","journal-title":"BMC Complement Altern Med"},{"key":"1283_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.brainresbull.2010.08.013","volume":"83","author":"H Tamano","year":"2010","unstructured":"Tamano H, Kan F, Oku N, Takeda A (2010) Ameliorative effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient young mice. Brain Res Bull 83:351\u2013355. \nhttps:\/\/doi.org\/10.1016\/j.brainresbull.2010.08.013","journal-title":"Brain Res Bull"},{"key":"1283_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2147\/NDT.S129418","volume":"13","author":"H Katahira","year":"2017","unstructured":"Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, Takashima M, Ishikawa S, Hisamitsu T (2017) Antistress effects of Kampo medicine \u201cYokukansan\u201d via regulation of orexin secretion. Neuropsychiatr Dis Treat 13:863\u2013872. \nhttps:\/\/doi.org\/10.2147\/NDT.S129418","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1283_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1742-2094-10-145","volume":"10","author":"M Furuya","year":"2013","unstructured":"Furuya M, Miyaoka T, Tsumori T, Liaury K, Hashioka S, Wake R, Tsuchie K, Fukushima M, Ezoe S, Horiguchi J (2013) Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat. J Neuroinflamm 10:145. \nhttps:\/\/doi.org\/10.1186\/1742-2094-10-145","journal-title":"J Neuroinflamm"},{"key":"1283_CR18","doi-asserted-by":"publisher","first-page":"870687","DOI":"10.1155\/2015\/870687","volume":"2015","author":"S Ebisawa","year":"2015","unstructured":"Ebisawa S, Andoh T, Shimada Y, Kuraishi Y (2015) Yokukansan improves mechanical allodynia through the regulation of interleukin-6 expression in the spinal cord in mice with neuropathic pain. Evid Based Complement Alternat Med 2015:870687. \nhttps:\/\/doi.org\/10.1155\/2015\/870687","journal-title":"Evid Based Complement Alternat Med"},{"key":"1283_CR19","doi-asserted-by":"publisher","first-page":"15205","DOI":"10.1038\/ncomms15205","volume":"16","author":"T Agalioti","year":"2017","unstructured":"Agalioti T, Giannou AD, Krontira AC, Kanellakis NI, Kati D, Vreka M, Pepe M, Spella M, Lilis I, Zazara DE, Nikolouli E, Spiropoulou N, Papadakis A, Papadia K, Voulgaridis A, Harokopos V, Stamou P, Meiners S, Eickelberg O, Snyder LA, Antimisiaris SG, Kardamakis D, Psallidas I, Marazioti A, Stathopoulos GT (2017) Mutant KRAS promotes malignant pleural effusion formation. Nat Commun 16:15205. \nhttps:\/\/doi.org\/10.1038\/ncomms15205","journal-title":"Nat Commun"},{"key":"1283_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2017","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragon L, Jacquelot L, Qu B, Ferrere G, Cl\u00e9menson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L (2017) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359:91\u201397. \nhttps:\/\/doi.org\/10.1126\/science.aan3706","journal-title":"Science"},{"key":"1283_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1155\/2015\/726471","volume":"25","author":"T Ueki","year":"2015","unstructured":"Ueki T, Mizoguchi K, Yamaguchi T, Nishi A, Ikarashi Y, Hattori T, Kase Y (2015) Yokukansan increases 5-HT1A receptors in the prefrontal cortex and enhances 5-HT1A receptor agonist-induced behavioral responses in socially isolated mice. Evid Based Complement Alternat Med 25:25. \nhttps:\/\/doi.org\/10.1155\/2015\/726471","journal-title":"Evid Based Complement Alternat Med"},{"key":"1283_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fphar.2017.00149","volume":"8","author":"K Mizoguchi","year":"2017","unstructured":"Mizoguchi K, Ikarashi Y (2017) Multiple psychopharmacological effects of the traditional Japanese Kampo medicine Yokukansan, and the brain regions it affects. Front Pharmacol 8:149. \nhttps:\/\/doi.org\/10.3389\/fphar.2017.00149","journal-title":"Front Pharmacol"},{"key":"1283_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuroscience.2012.01.037","volume":"207","author":"A Nishi","year":"2012","unstructured":"Nishi A, Yamaguchi T, Sekiguchi K, Imamura S, Tabuchi M, Kanno H, Nakai Y, Hashimoto K, Ikarashi Y, Kase Y (2012) Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience 207:124\u2013136. \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2012.01.037","journal-title":"Neuroscience"},{"key":"1283_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11940-007-0019-0","volume":"9","author":"L Fiorentino","year":"2007","unstructured":"Fiorentino L, Ancoli-Israel S (2007) Sleep dysfunction in patients with cancer. Curr Treat Options Neurol 9:337\u2013346","journal-title":"Curr Treat Options Neurol"},{"key":"1283_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, B\u00e9rard M, Nigou J, Opolon P, Eggermont A, Woerther PL, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:1079\u20131084. \nhttps:\/\/doi.org\/10.1126\/science.aad1329","journal-title":"Science"},{"key":"1283_CR26","doi-asserted-by":"publisher","first-page":"85318","DOI":"10.18632\/oncotarget.13347","volume":"7","author":"M Wu","year":"2016","unstructured":"Wu M, Wu Y, Deng B, Li J, Cao H, Qu Y, Qian X, Zhong G (2016) Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota. Oncotarget 7:85318\u201385331. \nhttps:\/\/doi.org\/10.18632\/oncotarget.13347","journal-title":"Oncotarget"},{"key":"1283_CR27","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0959-8049(03)00235-1","volume":"39","author":"F Ciardiello","year":"2003","unstructured":"Ciardiello F, Tortora G (2003) Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer 39:1348\u20131354","journal-title":"Eur J Cancer"},{"key":"1283_CR28","doi-asserted-by":"publisher","first-page":"e0187289","DOI":"10.1371\/journal.pone.0187289","volume":"12","author":"M Forcella","year":"2017","unstructured":"Forcella M, Oldani M, Epistolio S, Freguia S, Monti E, Fusi P, Frattini M (2017) Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: effect of the plasma membrane-associated NEU3. PLoS One 12:e0187289. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0187289","journal-title":"PLoS One"},{"issue":"3","key":"1283_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1245\/s10434-017-6181-z","volume":"24","author":"Y Morodomi","year":"2017","unstructured":"Morodomi Y, Okamoto T, Maehara Y (2017) Reply to \u201cEGFR mutation in patients with lung adenosquamous cell carcinoma\u201d. Ann Surg Oncol 24(3):676. \nhttps:\/\/doi.org\/10.1245\/s10434-017-6181-z","journal-title":"Ann Surg Oncol"},{"key":"1283_CR30","first-page":"48","volume":"2","author":"G Bethune","year":"2010","unstructured":"Bethune G, Bethune D, Ridgway N, Xu Z (2010) Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J Thorac Dis 2:48\u201351","journal-title":"J Thorac Dis"},{"key":"1283_CR31","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1002\/cam4.944","volume":"5","author":"J Pancewicz-Wojtkiewicz","year":"2016","unstructured":"Pancewicz-Wojtkiewicz J (2016) Epidermal growth factor receptor\u00a0and\u00a0notch\u00a0signaling\u00a0in\u00a0non-small-cell lung cancer. Cancer Med 5:3572\u20133578. \nhttps:\/\/doi.org\/10.1002\/cam4.944","journal-title":"Cancer Med"},{"key":"1283_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9\u201318","journal-title":"Cell Res"},{"key":"1283_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/1541-7786.MCR-07-2180","volume":"6","author":"EC Brantley","year":"2008","unstructured":"Brantley EC, Benveniste EN (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6:675\u2013684. \nhttps:\/\/doi.org\/10.1158\/1541-7786.MCR-07-2180","journal-title":"Mol Cancer Res"},{"key":"1283_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20:145\u2013155. \nhttps:\/\/doi.org\/10.1038\/nn.4476","journal-title":"Nat Neurosci"},{"key":"1283_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000355619","volume":"98","author":"B Meister","year":"2013","unstructured":"Meister B, Herzer S, Silahtaroglu A (2013) MicroRNAs in the hypothalamus. Neuroendocrinology 98:243\u2013253. \nhttps:\/\/doi.org\/10.1159\/000355619","journal-title":"Neuroendocrinology"},{"key":"1283_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.biopsych.2014.12.009","volume":"78","author":"M Geaghan","year":"2015","unstructured":"Geaghan M, Cairns MJ (2015) MicroRNA and posttranscriptional dysregulation in psychiatry. Biol Psychiatry 78:231\u2013239. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2014.12.009","journal-title":"Biol Psychiatry"},{"key":"1283_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1471-4159.2012.07925.x","volume":"123","author":"J Jin","year":"2012","unstructured":"Jin J, Cheng Y, Zhang Y, Wood W, Peng Q, Hutchison E, Mattson MP, Becker KG, Duan W (2012) Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J Neurochem 123:477\u2013490. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2012.07925.x","journal-title":"J Neurochem"},{"key":"1283_CR38","doi-asserted-by":"publisher","first-page":"276540","DOI":"10.1155\/2013\/276540","volume":"2013","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Yang GY (2013) MicroRNAs in cerebral ischemia. Stroke Res Treat 2013:276540. \nhttps:\/\/doi.org\/10.1155\/2013\/276540","journal-title":"Stroke Res Treat"},{"key":"1283_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3892\/ijmm.2017.2981","volume":"40","author":"J Zhu","year":"2017","unstructured":"Zhu J, Chen Z, Tian J, Meng Z, Ju M, Wu G, Tian Z (2017) miR-34b attenuates trauma-induced anxiety-like behavior by targeting CRHR1. Int J Mol Med 40:90\u2013100. \nhttps:\/\/doi.org\/10.3892\/ijmm.2017.2981","journal-title":"Int J Mol Med"},{"key":"1283_CR40","doi-asserted-by":"publisher","first-page":"5249893","DOI":"10.1155\/2016\/5249893","volume":"2016","author":"C Li","year":"2016","unstructured":"Li C, Liu Y, Liu D, Jiang H, Pan F (2016) Dynamic alterations of miR-34c expression in the hypothalamus of male rats after early adolescent traumatic stress. Neural Plast 2016:5249893. \nhttps:\/\/doi.org\/10.1155\/2016\/5249893","journal-title":"Neural Plast"},{"key":"1283_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.12731","volume":"130","author":"SP Jadhav","year":"2014","unstructured":"Jadhav SP, Kamath SP, Choolani M, Lu J, Dheen ST (2014) microRNA-200b modulates microglia-mediated neuroinflammation via the cJun\/MAPK pathway. J Neurochem 130:388\u2013401. \nhttps:\/\/doi.org\/10.1111\/jnc.12731","journal-title":"J Neurochem"},{"key":"1283_CR42","doi-asserted-by":"publisher","first-page":"35729","DOI":"10.1038\/srep35729","volume":"6","author":"C Beclin","year":"2016","unstructured":"Beclin C, Follert P, Stappers E, Barral S, Nathalie C, de Chevigny A, Magnone V, Lebrigand K, Bissels U, Huylebroeck D, Bosio A, Barbry P, Seuntjens E, Cremer H (2016) miR-200 family controls late steps of postnatal forebrain neurogenesis via Zeb2 inhibition. Sci Rep 6:35729. \nhttps:\/\/doi.org\/10.1038\/srep35729","journal-title":"Sci Rep"},{"issue":"4","key":"1283_CR43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbrc.2005.05.044","volume":"332","author":"L Gapter","year":"2005","unstructured":"Gapter L, Wang Z, Glinski J, NG KY (2005) Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun 332(4):1153\u20131161","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1283_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10549-010-0929-5","volume":"126","author":"H Ling","year":"2011","unstructured":"Ling H, Zhang Y, Ng KY, Chew EH (2011) Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 126(3):609\u2013620. \nhttps:\/\/doi.org\/10.1007\/s10549-010-0929-5","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1283_CR45","doi-asserted-by":"publisher","first-page":"e0122270","DOI":"10.1371\/journal.pone.0122270","volume":"10","author":"S Chen","year":"2015","unstructured":"Chen S, Swanson K, Eliaz I, McClintick JN, Sandusky GE, Sliva D (2015) Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress. PLoS One 10(4):e0122270. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0122270","journal-title":"PLoS One"},{"key":"1283_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12935-015-0230-0","volume":"15","author":"J Ma","year":"2015","unstructured":"Ma J, Liu J, Lu C, Cai D (2015) Pachymic acid induces apoptosis via activating ROS-dependent JNK and ER stress pathways in lung cancer cells. Cancer Cell Int 15:78. \nhttps:\/\/doi.org\/10.1186\/s12935-015-0230-0","journal-title":"Cancer Cell Int"},{"issue":"2","key":"1283_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/CAD.0000000000000449","volume":"28","author":"C Lu","year":"2017","unstructured":"Lu C, Ma J, Cai D (2017) Pachymic acid inhibits the tumorigenicity of gastric cancer cells by the mitochondrial pathway. Anticancer Drugs 28(2):170\u2013179. \nhttps:\/\/doi.org\/10.1097\/CAD.0000000000000449","journal-title":"Anticancer Drugs"},{"issue":"2","key":"1283_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10495-010-0557-x","volume":"16","author":"BM Kim","year":"2011","unstructured":"Kim BM, Hong SH (2011) Sequential caspase-2 and caspase-8 activation is essential for saikosaponin a-induced apoptosis of human colon carcinoma cell lines. Apoptosis 16(2):184\u2013197. \nhttps:\/\/doi.org\/10.1007\/s10495-010-0557-x","journal-title":"Apoptosis"},{"issue":"3","key":"1283_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1142\/S0192415X03001065","volume":"31","author":"JC Chen","year":"2003","unstructured":"Chen JC, Chang NW, Chung JG, Chen KC (2003) Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells. Am J Chin Med 31(3):363\u2013377","journal-title":"Am J Chin Med"},{"issue":"2","key":"1283_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2004.03.044","volume":"213","author":"YL Hsu","year":"2004","unstructured":"Hsu YL, Kuo PL, Chiang LC, Lin CC (2004) Involvement of p53, nuclear factor kappaB and Fas\/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Cancer Lett 213(2):213\u2013221","journal-title":"Cancer Lett"},{"issue":"10","key":"1283_CR51","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.lfs.2004.03.008","volume":"75","author":"YL Hsu","year":"2004","unstructured":"Hsu YL, Kuo PL, Lin CC (2004) The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci 75(10):1231\u20131242","journal-title":"Life Sci"},{"issue":"17","key":"1283_CR52","first-page":"2435","volume":"18","author":"RY Liu","year":"2014","unstructured":"Liu RY, Li JP (2014) Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest. Eur Rev Med Pharmacol Sci 18(17):2435\u20132443","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1283_CR53","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3892\/mmr.2017.6765","volume":"16","author":"Y Li","year":"2017","unstructured":"Li Y, Cai T, Zhang W, Zhu W, Lv S (2017) Effects of Saikosaponin D on apoptosis in human U87 glioblastoma cells. Mol Med Rep 16(2):1459\u20131464. \nhttps:\/\/doi.org\/10.3892\/mmr.2017.6765","journal-title":"Mol Med Rep"},{"issue":"7","key":"1283_CR54","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1440-1681.2004.04016.x","volume":"31","author":"YL Hsu","year":"2004","unstructured":"Hsu YL, Kuo PL, Chiang LC, Lin CC (2004) Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells. Clin Exp Pharmacol Physiol 31(7):414\u2013418","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1283_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.canlet.2003.10.023","volume":"207","author":"T Ii","year":"2004","unstructured":"Ii T, Satomi Y, Katoh D, Shimada J, Baba M, Okuym Y, Nishino H, Kitamura N (2004) Induction of cell cycle arrest and p21(CIP1\/WAF1) expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 207(1):27\u201335","journal-title":"Cancer Lett"},{"issue":"52","key":"1283_CR56","doi-asserted-by":"publisher","first-page":"35839","DOI":"10.1074\/jbc.M114.585513","volume":"289","author":"SK Jung","year":"2014","unstructured":"Jung SK, Lee MH, Lim DY, Kim JE, Singh P, Lee SY, Jeong CH, Lim TG, Chen H, Chi YI, Kundu JK, Lee NH, Lee CC, Cho YY, Bode AM, Lee KW, Dong Z (2014) Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R\/T790M mutant EGFR. J Biol Chem 289(52):35839\u201335848. \nhttps:\/\/doi.org\/10.1074\/jbc.M114.585513","journal-title":"J Biol Chem"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11418-019-01283-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-019-01283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-019-01283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T10:12:30Z","timestamp":1588068750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11418-019-01283-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s11418-019-01283-x","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"type":"print","value":"1340-3443"},{"type":"electronic","value":"1861-0293"}],"subject":[],"published":{"date-parts":[[2019,2,9]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}